Article / Mar 04, 2024
Continuous Tableting and the Road to Global Adoption
GMP Journal, 04 March 2024
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione is closer to its customers with a new website in Mandarin
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Hovione proudly announces its collaborative venture with Higuchi.
Hovione commitment to setting SBTs in line with the Paris Agreement